These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17966970)

  • 1. High osmolarity and L-DOPA augment release via the fusion pore in PC12 cells.
    Sombers LA; Wittenberg NJ; Maxson MM; Adams KL; Ewing AG
    Chemphyschem; 2007 Dec; 8(17):2471-7. PubMed ID: 17966970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loaded dopamine is preferentially stored in the halo portion of PC12 cell dense core vesicles.
    Sombers LA; Maxson MM; Ewing AG
    J Neurochem; 2005 Jun; 93(5):1122-31. PubMed ID: 15934933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of catecholamine-containing vesicles in PC12 cells.
    Westerink RH; de Groot A; Vijverberg HP
    Biochem Biophys Res Commun; 2000 Apr; 270(2):625-30. PubMed ID: 10753674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microelectrode array biochip: tool for in vitro drug screening based on the detection of a drug effect on dopamine release from PC12 cells.
    Cui HF; Ye JS; Chen Y; Chong SC; Sheu FS
    Anal Chem; 2006 Sep; 78(18):6347-55. PubMed ID: 16970308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure.
    Hondebrink L; Meulenbelt J; Timmerman JG; van den Berg M; Westerink RH
    J Neurochem; 2009 Oct; 111(2):624-33. PubMed ID: 19702656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP.
    Jin CM; Yang YJ; Huang HS; Lim SC; Kai M; Lee MK
    Eur J Pharmacol; 2008 Sep; 591(1-3):88-95. PubMed ID: 18602388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-3,4-dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro.
    Pothos E; Desmond M; Sulzer D
    J Neurochem; 1996 Feb; 66(2):629-36. PubMed ID: 8592133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intermittent L-DOPA treatment induces changes in dopamine release.
    Lundblad M; af Bjerkén S; Cenci MA; Pomerleau F; Gerhardt GA; Strömberg I
    J Neurochem; 2009 Feb; 108(4):998-1008. PubMed ID: 19196428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicore vesicles: hyperosmolarity and L-DOPA induce homotypic fusion of dense core vesicles.
    Sombers LA; Maxson MM; Ewing AG
    Cell Mol Neurobiol; 2007 Aug; 27(5):681-5. PubMed ID: 17554620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltammetric and pharmacological characterization of dopamine release from single exocytotic events at rat pheochromocytoma (PC12) cells.
    Kozminski KD; Gutman DA; Davila V; Sulzer D; Ewing AG
    Anal Chem; 1998 Aug; 70(15):3123-30. PubMed ID: 11013717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxidative stress induced by L-dopa on endogenous antioxidants in PC-12 cells.
    Vatassery GT; Smith WE; Quach HT
    Ann N Y Acad Sci; 2006 Aug; 1074():330-6. PubMed ID: 17105929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Transmembrane segments of syntaxin line the fusion pore of Ca2+-triggered exocytosis".
    Szule JA; Coorssen JR
    Science; 2004 Oct; 306(5697):813; author reply 813. PubMed ID: 15514140
    [No Abstract]   [Full Text] [Related]  

  • 13. Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity.
    Fornai F; Lenzi P; Lazzeri G; Ferrucci M; Fulceri F; Giorgi FS; Falleni A; Ruggieri S; Paparelli A
    Brain Res; 2007 Jan; 1129(1):174-90. PubMed ID: 17157274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of scoparone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells.
    Yang YJ; Lee HJ; Huang HS; Lee BK; Choi HS; Lim SC; Lee CK; Lee MK
    J Neurosci Res; 2009 Jun; 87(8):1929-37. PubMed ID: 19185027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of vesicular volume on secretion through the fusion pore in exocytotic release from PC12 cells.
    Sombers LA; Hanchar HJ; Colliver TL; Wittenberg N; Cans A; Arbault S; Amatore C; Ewing AG
    J Neurosci; 2004 Jan; 24(2):303-9. PubMed ID: 14724228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring dopamine release from single living vesicles with nanoelectrodes.
    Wu WZ; Huang WH; Wang W; Wang ZL; Cheng JK; Xu T; Zhang RY; Chen Y; Liu J
    J Am Chem Soc; 2005 Jun; 127(25):8914-5. PubMed ID: 15969544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative investigations of amperometric spike feet suggest different controlling factors of the fusion pore in exocytosis at chromaffin cells.
    Amatore C; Arbault S; Bonifas I; Guille M
    Biophys Chem; 2009 Aug; 143(3):124-31. PubMed ID: 19501951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-DOPA attenuates hyperactivity of Roborovskii hamsters.
    Kabuki Y; Shigemi K; Hamasu K; Furuse M
    Behav Pharmacol; 2009 May; 20(3):260-4. PubMed ID: 19404194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
    Matsushita N; Misu Y; Goshima Y
    Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.
    Rangel-Barajas C; Silva I; García-Ramírez M; Sánchez-Lemus E; Floran L; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2008 Oct; 55(5):704-11. PubMed ID: 18588904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.